MARKET

BBNX

BBNX

Beta Bionics, Inc.
NASDAQ
21.51
-0.25
-1.15%
Closed 19:30 09/25 EDT
OPEN
21.74
PREV CLOSE
21.76
HIGH
21.98
LOW
21.25
VOLUME
926.01K
TURNOVER
--
52 WEEK HIGH
32.71
52 WEEK LOW
8.80
MARKET CAP
1.13B
P/E (TTM)
-13.0514
1D
5D
1M
3M
1Y
5Y
1D
Beta Bionics Price Target Raised to $28.00/Share From $23.00 by Truist Securities
Dow Jones · 3d ago
Beta Bionics Is Maintained at Buy by Truist Securities
Dow Jones · 3d ago
Truist Securities Maintains Buy on Beta Bionics, Raises Price Target to $28
Benzinga · 3d ago
Beta Bionics, Inc. (BBNX) Receives a Buy from Truist Financial
TipRanks · 4d ago
Beta Bionics Price Target Announced at $28.00/Share by Wells Fargo
Dow Jones · 4d ago
Wells Fargo Initiates Coverage On Beta Bionics with Overweight Rating, Announces Price Target of $28
Benzinga · 4d ago
Beta Bionics initiated with an Overweight at Wells Fargo
TipRanks · 5d ago
Wall Street Analysts Are Bullish on Top NA Picks
TipRanks · 5d ago
More
About BBNX
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.

Webull offers Beta Bionics, Inc. stock information, including NASDAQ: BBNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBNX stock methods without spending real money on the virtual paper trading platform.